Strategic Planning
Michael Pencina, chief data scientist at Duke AI Health, discusses strategic and intentional AI implementation within healthcare systems to ensure correct AI model use, healthcare provider utilization and objective evaluation of AI offerings.
Kelly Arduino, a healthcare industry leader at advisory firm Wipfli, discusses susceptibility to cyberattacks in small and large healthcare systems, especially in rural areas.
HIMSS senior market insights manager Nicole Ramage discusses new research that explores what executive and IT leaders are saying about the challenges and benefits of using artificial intelligence.
Dr. Eve Cunningham, chief of virtual care and digital health at Providence, discusses clinician response to AI, promoting education and engagement within the healthcare workforce and how AI can help providers stay current on patient care.
Sunil Dadlani, EVP and chief information and digital officer at Atlantic Health System, discusses possible unintentional impacts on stakeholders in healthcare with AI implementation and pinpointing priorities to mitigate complications.
At the HIMSS AI in Healthcare Forum in Boston, CEO of HIMSS Hal Wolf highlights the challenges health systems face globally integrating AI, leveraging the technology to ensure beneficial healthcare delivery and regulations pertaining to AI.
Organizations need to ask how they can secure their use of AI technologies, use AI to secure the organization better and defend against AI-driven attacks, says Dave Heaney, chief information security officer at Mass General Brigham.
Dr Alexander Ryu, vice chair of Innovation and AI at Mayo Clinic, reveals best practices in planning and integrating AI into clinical practice.
Robert Booker, chief strategy officer at HITRUST, discusses how the company is adjusting its risk and data management guidance for healthcare providers to ensure cybersecurity after the emergence of new threats posed by genAI in society.
QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.